Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 75,000 shares at $1.34 ($100K) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Open-market purchase of $100k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |
| MAIA | BUY | 2025-11-26 | $25K | — | Filing → |